Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.
2.
3.

The prophylactic effect of valproate on glyceryltrinitrate induced migraine.

Tvedskov JF, Thomsen LL, Iversen HK, Gibson A, Wiliams P, Olesen J.

Cephalalgia. 2004 Jul;24(7):576-85.

PMID:
15196300
4.

Vestibulo-ocular reflex in migraine patients: the effect of sodium valproate.

Gordon CR, Kuritzky A, Doweck I, Spitzer O, Shupak A, Hering R.

Headache. 1993 Mar;33(3):129-32.

PMID:
8486508
5.

Migraine prophylaxis with divalproex.

Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, Rapoport AM, Silber CJ, Deaton RL.

Arch Neurol. 1995 Mar;52(3):281-6.

PMID:
7872882
6.

Prophylactic sodium valproate therapy in patients with drug-resistant migraine.

Ghose K, Niven B.

Methods Find Exp Clin Pharmacol. 1998 May;20(4):353-9.

PMID:
9658386
7.

Sodium valproate prophylaxis in childhood migraine.

Serdaroglu G, Erhan E, Tekgul H, Oksel F, Erermis S, Uyar M, Tutuncuoglu S.

Headache. 2002 Sep;42(8):819-22.

PMID:
12390647
8.

Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.

Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM; BOTOX North American Episodic Migraine Study Group..

Headache. 2007 Apr;47(4):486-99.

PMID:
17445098
9.

Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine.

Waberzinek G, Marková J, Mastík J.

Neuro Endocrinol Lett. 2007 Feb;28(1):59-64.

PMID:
17277725
10.

A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.

Freitag FG, Collins SD, Carlson HA, Goldstein J, Saper J, Silberstein S, Mathew N, Winner PK, Deaton R, Sommerville K; Depakote ER Migraine Study Group..

Neurology. 2002 Jun 11;58(11):1652-9.

PMID:
12058094
11.

Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial.

Sarchielli P, Messina P, Cupini LM, Tedeschi G, Di Piero V, Livrea P, Pini LA, Bernardi G, Bono G, Sandrini G, Caproni S, Corbelli I, Pisani F, Beghi E, Calabresi P; SAMOHA Study Group..

Eur Neuropsychopharmacol. 2014 Aug;24(8):1289-97. doi: 10.1016/j.euroneuro.2014.03.010. Epub 2014 Apr 5.

PMID:
24862255
12.

Sodium Valproate versus Propranolol in paediatric migraine prophylaxis.

Ashrafi MR, Shabanian R, Zamani GR, Mahfelati F.

Eur J Paediatr Neurol. 2005;9(5):333-8. Epub 2005 Aug 24.

PMID:
16120482
13.

Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.

Cady RK, Mathew N, Diener HC, Hu P, Haas M, Novak GP; Study Group..

Headache. 2009 Feb;49(2):216-26. doi: 10.1111/j.1526-4610.2008.01326.x.

PMID:
19222595
14.
15.
16.
17.

Valproate: a new drug in migraine prophylaxis.

Sørensen KV.

Acta Neurol Scand. 1988 Oct;78(4):346-8.

PMID:
3146862
18.

Sodium valproate in severe migraine and tension-type headache: an open study of long-term efficacy and correlation with blood levels.

Lenaerts M, Bastings E, Sianard J, Schoenen J.

Acta Neurol Belg. 1996 Jun;96(2):126-9.

PMID:
8711985
19.

Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.

Dowson AJ, Charlesworth BR, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.

CNS Drugs. 2003;17(11):839-51.

PMID:
12921494
20.

Divalproex sodium in headache: literature review and clinical guidelines.

Silberstein SD.

Headache. 1996 Oct;36(9):547-55. Review.

PMID:
8916563

Supplemental Content

Support Center